Your browser doesn't support javascript.
loading
Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.
Broadfield, Lindsay A; Duarte, João André Gonçalves; Schmieder, Roberta; Broekaert, Dorien; Veys, Koen; Planque, Mélanie; Vriens, Kim; Karasawa, Yasuaki; Napolitano, Francesco; Fujita, Suguru; Fujii, Masashi; Eto, Miki; Holvoet, Bryan; Vangoitsenhoven, Roman; Fernandez-Garcia, Juan; Van Elsen, Joke; Dehairs, Jonas; Zeng, Jia; Dooley, James; Rubio, Rebeca Alba; van Pelt, Jos; Grünewald, Thomas G P; Liston, Adrian; Mathieu, Chantal; Deroose, Christophe M; Swinnen, Johannes V; Lambrechts, Diether; di Bernardo, Diego; Kuroda, Shinya; De Bock, Katrien; Fendt, Sarah-Maria.
Afiliación
  • Broadfield LA; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Duarte JAG; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Schmieder R; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Broekaert D; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Veys K; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Planque M; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Vriens K; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Karasawa Y; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Napolitano F; Department of Oncology (KU Leuven) and Center for Cancer Biology (VIB), Laboratory of Angiogenesis and Vascular Metabolism, Leuven, Belgium.
  • Fujita S; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Fujii M; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Eto M; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Holvoet B; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Vangoitsenhoven R; Department of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.
  • Fernandez-Garcia J; Department of Neurosurgery, University of Tokyo Hospital, Tokyo, Japan.
  • Van Elsen J; Department of Rehabilitation, University of Tokyo Hospital, Tokyo, Japan.
  • Dehairs J; Telethon Institute of Genetics and Medicine (TIGEM), System Biology and Bioinformatics Laboratory and High Content Screening Facility, Naples, Italy.
  • Zeng J; Department of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.
  • Dooley J; Department of Mathematical and Life Sciences, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
  • Rubio RA; Department of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.
  • van Pelt J; Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven, Belgium.
  • Grünewald TGP; Department of Endocrinology, UZ Gasthuisberg KU Leuven, Leuven, Belgium.
  • Liston A; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Mathieu C; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Deroose CM; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Swinnen JV; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Lambrechts D; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven Cancer Institute, Leuven, Belgium.
  • di Bernardo D; School of Life Science, Hunan University of Science and Technology, Xiangtan, Hunan, China.
  • Kuroda S; Department of Microbiology and Immunology, KU Leuven; and Translational Immunology Laboratory, Leuven, Belgium.
  • De Bock K; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, Munich, Germany.
  • Fendt SM; Department of Oncology, Laboratory of Clinical Digestive Oncology, KU, Leuven, Belgium.
Cancer Res ; 81(8): 1988-2001, 2021 04 15.
Article en En | MEDLINE | ID: mdl-33687947
ABSTRACT
Hepatic fat accumulation is associated with diabetes and hepatocellular carcinoma (HCC). Here, we characterize the metabolic response that high-fat availability elicits in livers before disease development. After a short term on a high-fat diet (HFD), otherwise healthy mice showed elevated hepatic glucose uptake and increased glucose contribution to serine and pyruvate carboxylase activity compared with control diet (CD) mice. This glucose phenotype occurred independently from transcriptional or proteomic programming, which identifies increased peroxisomal and lipid metabolism pathways. HFD-fed mice exhibited increased lactate production when challenged with glucose. Consistently, administration of an oral glucose bolus to healthy individuals revealed a correlation between waist circumference and lactate secretion in a human cohort. In vitro, palmitate exposure stimulated production of reactive oxygen species and subsequent glucose uptake and lactate secretion in hepatocytes and liver cancer cells. Furthermore, HFD enhanced the formation of HCC compared with CD in mice exposed to a hepatic carcinogen. Regardless of the dietary background, all murine tumors showed similar alterations in glucose metabolism to those identified in fat exposed nontransformed mouse livers, however, particular lipid species were elevated in HFD tumor and nontumor-bearing HFD liver tissue. These findings suggest that fat can induce glucose-mediated metabolic changes in nontransformed liver cells similar to those found in HCC.

SIGNIFICANCE:

With obesity-induced hepatocellular carcinoma on a rising trend, this study shows in normal, nontransformed livers that fat induces glucose metabolism similar to an oncogenic transformation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Grasas de la Dieta / Carcinoma Hepatocelular / Hepatocitos / Dieta Alta en Grasa / Glucosa / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Grasas de la Dieta / Carcinoma Hepatocelular / Hepatocitos / Dieta Alta en Grasa / Glucosa / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Bélgica